IFNA1 and metabolic disease: Targeting the cGAS-cGAMP-STING pathway in adipose tissue may provide another approach to ameliorate obesity-associated inflammation and metabolic disorders by downregulating the levels of proinflammatory genes, including IFN-α [127].